Topic: Technology Licensing

Latest content

Put patent policy to work to achieve climate goals

Saturday Opinion: Fabrice Mattei of Rouse says two measures that emerged from last month's COP26 climate summit can reshape the future of the patent system

11 December 2021

JPO to update SEP negotiation guide in 2022, commissioner says

Commissioner Kiyoshi Mori highlights 2018 document’s balance and the open, transparent process that went into its creation

09 December 2021

Revealed: first Chinese target of ZTE's new SEP licensing push

Court documents show that ZTE has filed a patent suit against Tinno Mobile, the Shenzhen-based company that owns French smartphone brand Wiko

08 December 2021

Germany’s new government is the last hope for covid IP waiver advocates

A post-Merkel change of approach by the country’s recently agreed traffic light coalition government could change the momentum of TRIPS suspension talks – but don’t bet on it

07 December 2021

Major US and UK SEP/FRAND reviews will have global licensing impact

Biden administration flags revised policy statement that rolls-back on original 2019 version, while the British government begins development of post-Brexit approach

07 December 2021

IP leaders weigh in on what makes or breaks a patent pool

From the need for clarity to the problems of self-certification, top practitioners give their prescriptions for making the most of the pool model

07 December 2021

CAFC tees up patent fight over multi-billion-dollar Moderna covid revenues

Arbutus Biopharma’s shares soar in anticipation of mRNA jab royalty lawsuit after Federal Circuit ruling

03 December 2021

Corporate tech transfer is on the rise, say chief IP officers

Convergence is making partnerships more important, with deals including not just licensing but also know-how, source code and technical support

01 December 2021

Data monetisation drives Sanofi’s $180 million investment in AI biotech Owkin

The deal shows how privacy and silo barriers to the commercialisation of information are being overcome

29 November 2021

Novo Nordisk’s $3.3 billion Dicerna purchase shows booming RNA IP market

Danish company makes its biggest-ever acquisition in an area where demand for assets is growing rapidly

23 November 2021

Get unlimited access to all IAM content